Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
24.01
+0.08 (0.33%)
At close: Apr 17, 2026, 4:00 PM EDT
23.55
-0.46 (-1.92%)
After-hours: Apr 17, 2026, 6:28 PM EDT

Bicara Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Bicara Therapeutics stock have a consensus rating of "Buy" and an average price target of $28, which forecasts a 16.62% increase in the stock price over the next year. The lowest target is $16 and the highest is $42.

Price Target: $28 (+16.62%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$16$28$30$42
Change-33.36%+16.62%+24.95%+74.93%

Analyst Ratings

The average analyst rating for Bicara Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy112233
Buy334433
Hold122233
Sell000000
Strong Sell000000
Total568899

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Hold
Maintains
$14$16
HoldMaintains$14$16-33.36%Mar 31, 2026
Wedbush
Wedbush
Buy
Reiterates
$30
BuyReiterates$30+24.95%Mar 31, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$11$16
HoldMaintains$11$16-33.36%Mar 31, 2026
Citizens
Citizens
Buy
Reiterates
$31
BuyReiterates$31+29.11%Mar 31, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$40$42
Strong BuyMaintains$40$42+74.93%Mar 31, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.71
from -2.52
EPS Next Year
-3.01
from -2.71
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
------14.51M
Revenue Growth
-------
EPS
-88.20-89.61-4.05-2.52-2.71-3.01-3.07
EPS Growth
-------
Forward PE
-------
No. Analysts
----161512
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-2.43-2.24
Avg-2.71-3.01
Low-2.80-4.05

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.